Voriconazole Powder, For Suspension
Product Images NDC 72673-111

Product Visual Gallery

This gallery contains 12 technical images submitted to the FDA as part of the official labeling for Voriconazole (NDC 72673-111). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Zhejiang Poly Pharm Co., Ltd., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Image 01)

FDA Label Image

Picture1 (Image 02)

FDA Label Image

Picture2 (Image 03)

FDA Label Image

Picture3 (Image 04)

FDA Label Image

Picture4 (Image 05)

FDA Label Image

Picture5 (Image 06)

FDA Label Image

Picture6 (Image 07)

FDA Label Image

Picture7 (Image 08)

FDA Label Image

Picture8 (Image 09)

FDA Label Image

Picture9 (Image 10)

FDA Label Image

Picture10 (Image 11)

FDA Label Image

40 mg/ml Bottle Label (Image 12)

This is a description for an oral suspension medication called Voriconazole. It contains 40mg/mL of Voriconazole and should be stored at controlled room temperature. The reconstituted suspension is orange flavored and should be discarded 14 days after reconstitution. The mixing directions require adding water to the powder and shaking vigorously before use. Each 75mL reconstituted suspension contains 40mg of Voriconazole. It is recommended to use it as directed.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.